{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-019866","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.947762+00:00","generated_at":"2026-05-26T22:14:58.270709+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"confidence":"high","headline":"Clearside Biomedical receives Nasdaq minimum bid price deficiency notice","bullets":["Notice received Feb 7, 2025; stock below $1.00 for 30 consecutive business days.","Company has 180 days (until Aug 6, 2025) to regain compliance.","To cure, bid price must close at $1.00+ for 10 consecutive business days.","Options include transfer to Nasdaq Capital Market or reverse stock split.","Failure to comply may result in delisting; company intends to monitor and seek remedies."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-019866","json":"https://secwatch.observer/filing/0000950170-25-019866.json","markdown":"https://secwatch.observer/filing/0000950170-25-019866.md","text":"https://secwatch.observer/filing/0000950170-25-019866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/0000950170-25-019866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/clsd-20250207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:14:58.270709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a82228f1716d8d6b356192a8345b0975aab07d85","claim":"Clearside Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"February 7, 2025, Clearside Biomedical, Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/0000950170-25-019866-index.htm","confidence":0.9}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}